Pharmaceutical Excipients Market Size Worth USD 10.43 Billion in 2032 | Emergen Research

Vancouver, Dec. 04, 2023 (GLOBE NEWSWIRE) -- The global pharmaceutical excipients market size was USD 6.00 Billion in 2022 and is expected to register a rapid revenue CAGR of 5.7% during the forecast period. The global pharmaceutical excipients market is experiencing substantial growth, primarily fueled by the rising demand for functional excipients and oral pharmaceutical medicines worldwide. The market is also driven by the expansion of pharmaceutical industries and an increasing preference for generic medications. Pharmaceutical excipients, inert chemicals integral to drug manufacturing, play a pivotal role in enhancing stability, solid formulations, and drug absorption.

Key Factors Driving Market Growth:

• Functional Excipients and Oral Medicines Demand: The escalating demand for functional excipients and oral pharmaceutical medicines is a significant driver of market revenue growth. These excipients are crucial in preparing pharmaceuticals, providing solid formulations, improving stability, and enhancing drug absorption.
• Rise in Generic Medications: The increasing demand for generic medications, particularly after the expiration of patents, contributes to market growth. Generic drugs offer cost savings, with prices typically 60%–70% less than brand-name drugs, leading to substantial savings, especially in countries like India with high per capita spending.
• Chronic Disease Prevalence: The growing prevalence of chronic diseases worldwide further propels the demand for pharmaceutical excipients, as these are essential in formulating medications for disease management.
• Regulatory Challenges: Despite the positive trends, market growth faces challenges from regulatory strictness regarding drug and excipient approvals, along with the costly and time-consuming drug development process. Harmonizing regulatory criteria globally and ensuring consistent quality of generic pharmaceuticals are critical concerns.

Recent Market Trends:

• Biopharmaceutical Industry Growth: The market witnesses a rapid expansion of the biopharmaceuticals industry, driven by the popularity of biomolecule-based drugs. Pharmaceutical companies globally are increasingly focusing on Research & Development (R&D) for biopharmaceutical products.
• Formulation Insights: In 2022, the topical segment dominated the market revenue share due to the increasing adoption of topical medication delivery, providing high therapeutic outcomes. Tablets are expected to register moderate growth, driven by their widespread use in dosage forms.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2539 

Functionality Insights:

• Fillers and Diluents Lead: The fillers and diluents segment is expected to hold a significant revenue share, driven by their use in oral medications to enhance stability, reduce weight fluctuation, and improve dosing accuracy.
• Binder Segment Growth: Binders are expected to experience steady growth due to their role in enhancing mechanical strength, disintegration, bulkiness, bioavailability, and dissolution rate in pharmaceutical products.

Product Insights:

• Inorganic Excipients Growth: The inorganic excipients segment is poised to register the fastest revenue growth, attributed to the increasing demand for stable dosage forms that withstand transportation and storage challenges.
• Organic Excipients Dominance: Organic excipients, sourced from natural origins, are expected to account for the largest revenue share, driven by their biocompatibility, compatibility with biological systems, and relevance in novel medication formulations.

Regional Insights:

• North America Dominance: North America held the largest revenue share in 2022, driven by the demand for functional excipients and technological advancements. Functional excipients play a crucial role in enhancing therapeutic efficacy and drug delivery.
• Asia Pacific's Rapid Growth: The Asia Pacific market is poised for the fastest growth, fueled by the presence of major players in developing countries, low manufacturing costs, and an increasing need for pharmaceutical excipients.
• Europe's Strong Presence: Europe is expected to account for a considerable revenue share, driven by investments in biologics and superior dosage forms. Key industry players in the region actively engage in partnerships, collaborations, and product innovations.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/2539

Scope of Research

MAJOR COMPANIES and Market Share Analysis

The global pharmaceutical excipients market is moderately fragmented, with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective pharmaceutical excipients solutions. Some major players included in the global pharmaceutical excipients market report are:

• Evonik Industries
• Ashland Global Holdings, Inc.
• International Flavors & Fragrances, Inc.
• Roquette Frères
• Fuji Chemical Industries Co., Ltd.
• Wacker Chemie AG
• Meggle GmbH & Co Kg
• Fuji Chemical Industries Co., Ltd.
• Ideal Cures Pvt. Ltd.
• Biogrund GmbH
• Nitika Pharmaceutical Specialties Pvt. Ltd.
• J.M. Huber Corporation
• Kerry
• Colorcon
• Merck Millipore
• Ashland
• DFE Pharma
• Finar Limited
• Corel Pharma Chem
• Roquette

Strategic Development

• On 3 October, 2022, Ashland a, company manufacturing drugs with new technological advancements, such as matrix polymer, launched klucel xtend HPC. Klucel xtend HPC is the only cellulosic excipient that offers a complete extended-release polymer alternative for Hot-Melt Extrusion (HME).
• In February 2022, Kerry Group Plc., the world’s leading taste and nutrition company, revealed the acquisition of two significant biotechnology companies. These acquisitions strengthened Kerry Group Plc’s technology portfolio, manufacturing capabilities, and expertise. Enmex, a Mexican enzyme manufacturer, and c-LEcta, a leading biotechnology innovation company, have been acquired by the company.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2539

Segments Covered in Report

For the purpose of this report, Emergen Research has segmented the global pharmaceutical excipients market on the basis of formulation, product, functionality, end-use, and region:

• Formulation Outlook (Revenue, USD Billion; 2019-2032)
  • Tablets
  • Parenterals
  • Capsules
  • Topicals
  • Others
• Functionality Outlook (Revenue, USD Billion; 2019-2032)
  • Fillers and Diluents
  • Binders
  • Disintegrants
  • Lubricants and Glidants
  • Flavoring Agents & Sweeteners
  • Others
• Product Outlook (Revenue, USD Billion; 2019-2032)
  • Organic Excipients
  • Inorganic Excipients
• End-use Industry Vertical Outlook (Revenue, USD Billion; 2019-2032)
  • Pharmaceutical and Biopharmaceutical Companies
  • Research Organizations
  • Contract Formulators
• Regional Outlook (Revenue, USD Billion; 2019–2032)
  • North America
    1. U.S.
    2. Canada
    3. Mexico
  • Europe
    1. Germany
    2. France
    3. UK
    4. Italy
    5. Spain
    6. Benelux
    7. Rest of Europe
  • Asia Pacific
    1. China
    2. India
    3. Japan
    4. South Korea
    5. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • Middle East & Africa
    1. Saudi Arabia
    2. UAE
    3. South Africa
    4. Turkey
    5. Rest of Middle East & Africa

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/pharmaceutical-excipients-market

Curated Reports You Shouldn't Miss: Dive In Now!

Biobanking Market Size, Share, Trends, By Product & Services (Equipment, Consumables, Services, Software), By Sample Type (Biological Fluids, Human Tissues, Blood Products), By Storage Type, By Application, and By Region Forecast to 2030

Protein Chip Market, By Technology (Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarray), By Application (Diagnostics, Proteomics, Antibody Characterization), By End-Use, and By Region Forecast to 2030

Stool Softener Market, By Form (Medicines, Procedures), By Mode of Administration (Oral, Rectal), Availability (Over-the-Counter, Prescription), By End-Use (Hospitals, Clinics), and by Region Forecast to 2030

CAR-T cell therapy Market, By Type (Abecma, Breyanzi, Kymriah, Yescarta), By Indication (Diffuse Large B-cell Lymphoma, Multiple Myeloma, Follicular Lymphoma), By End-Use (Hospitals, Cancer Treatment Centers), and By Region Forecast to 2030

Hospital Gowns Market, By Usability (Disposable Gowns and Reusable Gowns), By Type (Surgical, Non-Surgical, and Patient), By Risk Level (Minimal, Low, High, Others), By Region Forecast to 2030

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights